Manel Rakez

Manel Rakez

Université de Bordeaux - Bordeaux / France
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 5772105
University of Bordeaux
person_outline Manel Rakez's MOST POPULAR ARTICLES
1-) Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR GroupT André, D Vernerey, SA Im, G Bodoky, R Buzzoni, S Reingold, F Rivera, ...Annals of Oncology 31 (2), 246-256, 2020292020
2-) Association of bevacizumab plus oxaliplatin-based chemotherapy with disease-free survival and overall survival in patients with stage II colon cancer: a secondary analysis of …B Chibaudel, J Henriques, M Rakez, B Brenner, TW Kim, ...JAMA network open 3 (10), e2020425-e2020425, 2020152020
3-) Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database.AD Wagner, M Rakez, B Chibaudel, R Adams, JR Zalcberg, LB Saltz, ...Journal of Clinical Oncology 38 (15_suppl), 4029-4029, 2020122020
4-) Benefit of oxaliplatin in stage III colon cancer according to IDEA risk groups: findings from the ACCENT database of 4934 patientsO Margalit, B Boursi, M Rakez, A Thierry, G Yothers, N Wolmark, ...Clinical colorectal cancer 20 (2), 130-136, 202172021
5-) Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in …JB Bachet, B Chibaudel, M Rakez, RM Goldberg, NC Tebbutt, ...Journal of Clinical Oncology 39 (15_suppl), 3575-3575, 202122021